Austrália - inglês - Department of Health (Therapeutic Goods Administration)

seqirus pty ltd - influenza virus haemagglutinin, quantity: 30 microgram/ml - injection, suspension - excipient ingredients: monobasic potassium phosphate; thiomersal; calcium chloride dihydrate; dibasic sodium phosphate; sodium chloride; potassium chloride; monobasic sodium phosphate; water for injections - indicated for the prevention of influenza caused by influenza virus, types a and b.

Austrália - inglês - Department of Health (Therapeutic Goods Administration)

seqirus pty ltd - influenza virus haemagglutinin -

Reino Unido - inglês - MHRA (Medicines & Healthcare Products Regulatory Agency)

split virion, inactivated) suspension for injection 0.5ml pre-filled syringes (sanofi - influenza virus split virion - suspension for injection

Nova Zelândia - inglês - Medsafe (Medicines Safety Authority)

seqirus (nz) ltd - influenza virus type a haemagglutinin 30ug (pandemic influenza virus haemagglutinin) - suspension for injection - 30 mcg/0.5ml - active: influenza virus type a haemagglutinin 30ug (pandemic influenza virus haemagglutinin) excipient: aluminium as aluminium phosphate adjuvant calcium chloride dibasic sodium phosphate monobasic potassium phosphate monobasic sodium phosphate potassium chloride sodium chloride thiomersal water for injection - prophylaxis of influenza in an officially declared pandemic situation. the vaccine may only be marketed or distributed in accordance with the directive contained in the current version of the new zealand influenza pandemic action plan.

União Europeia - inglês - EMA (European Medicines Agency)

sanofi pasteur - influenza a virus subtype h1n1 haemagglutinin, recombinant, influenza a virus subtype h3n2 haemagglutinin, recombinant, influenza b virus victoria lineage haemagglutinin, recombinant, influenza b virus yamagata lineage haemagglutinin, recombinant - influenza, human - vaccines - supemtek is indicated for active immunization for the prevention of influenza disease in adults.supemtek should be used in accordance with official recommendations.

Austrália - inglês - APVMA (Australian Pesticides and Veterinary Medicines Authority)

boehringer ingelheim animal health australia pty. ltd. - canine parainfluenza; bordetella bronchiseptica; canine adeno virus type 2 - misc. vaccines or anti sera - canine parainfluenza vaccine active 0.0 p; bordetella bronchiseptica vaccine-microbial active 0.0 p; canine adeno virus type 2 vaccine-viral active 0.0 p - immunotherapy - dog - over 8 weeks - bordetella bronchiseptica | canine adenovirus - type 2 | canine parainfluenza | canine cough syndrome | infectious tracheobronchitis

União Europeia - inglês - EMA (European Medicines Agency)

medimmune llc - reassortant influenza virus (live attenuated) of the following strains:a/california/7/2009 (h1n1)pdm09 like strain, a/victoria/361/2011 (h3n2) like strain, b/massachusetts/2/2012 like strain - influenza, human; immunization - vaccines - prophylaxis of influenza in individuals 24 months to less than 18 years of age.the use of fluenz should be based on official recommendations.

Nova Zelândia - inglês - Ministry for Primary Industries

ministry for primary industries - avian influenza type a, subtype h5n2 - avian influenza type a, subtype h5n2 0 vaccine - vaccine

Estados Unidos - inglês - NLM (National Library of Medicine)

novartis vaccines and diagnostics limited - influenza a virus a/california/7/2009 x-181 (h1n1) antigen (formaldehyde inactivated) (unii: 872508x6jg) (influenza a virus a/california/7/2009 x-181 (h1n1) hemagglutinin antigen (formaldehyde inactivated) - unii:5cl7878s2q) - influenza a virus a/california/7/2009 x-181 (h1n1) antigen (formaldehyde inactivated) 15 ug in 0.5 ml

Estados Unidos - inglês - NLM (National Library of Medicine)

protein sciences corporation - influenza a virus a/michigan/45/2015 (h1n1) recombinant hemagglutinin antigen (unii: 69h0yj871t) (influenza a virus a/michigan/45/2015 (h1n1) recombinant hemagglutinin antigen - unii:69h0yj871t) - influenza a virus a/michigan/45/2015 (h1n1) recombinant hemagglutinin antigen 45 ug in 0.5 ml